QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1 期刊论文 GASTROENTEROLOGY, 2019, 卷号: 156, 期号: 6 作者:  Li, Hui;  Li, Chia-Wei;  Li, Xiaoqiang;  Din, Qingqing;  Guo, Lei 收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05 Programmed Cell Death Ligand 1  Hepatocellular Carcinoma  Tumor Necrosis Factor Receptor-Associated Factor 6  Glycogen Synthase Kinase 3   PD1 protein expression in tumor infiltrated lymphocytes rather than PDL1 in tumor cells predicts survival in triple-negative breast cancer 期刊论文 2018, 卷号: 19, 期号: 5, 页码: 373-380 作者:  Ren, Xinyu;  Wu, Huanwen;  Lu, Junliang;  Zhang, Yuhan;  Luo, Yufeng 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 basal-like breast cancer (BLBC)  Immunohistochemistry  triple negative breast cancer (TNBC)  programmed cell death protein 1(PD1)  programmed cell death ligand 1(PDL1)  tumor-infiltrating lymphocytes (TILs)  RNAscope   Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer 期刊论文 ONCOTARGET, 2017, 卷号: 8, 页码: 7614-7624 作者:  Ma, Yun-Feng;  Chen, Chen;  Li, Dongqing;  Liu, Min;  Lv, Zhuang-Wei 收藏  |  浏览/下载：10/0  |  提交时间：2019/11/26 immunotherapy  breast cancer  interleukin-17  estrogen receptor  programmed death ligand 1   PERK-Phosphorylated eIF2 alpha Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer 期刊论文 CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2017, 卷号: 32, 期号: 8, 页码: 282-287 作者:  Zou, Weiwei;  Bai, Yu;  Wang, Xilong;  Cheng, Kai;  Sun, Hongguang 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/12 CXCL5  drug resistance  p-eIF2 alpha  PDL1  triple-negative breast  cancer   Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 5 作者:  Ma, Yun-Feng;  Chen, Chen;  Li, Dongqing;  Liu, Min;  Lv, Zhuang-Wei 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 interleukin-17  programmed death ligand 1  breast cancer  estrogen receptor  immunotherapy   Enhanced Anti-PDL1(+) Cancer Activity of DM1-Loaded-PLA-TPGS Nanoparticles Mediated with MPDL3280A 期刊论文 JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2016, 卷号: 16, 期号: 7 作者:  Tang, Xiaolong;  Lyu, Yanguan;  Zhu, Yongqiang;  Hou, Wei;  Liang, Yong 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 MPDL3280A  Emtansine (DM1)  Programmed Death-1 Ligand (PDL1)  Targeting Nanoparticles  Drug Delivery   The advantages of PD1 activating chimeric receptor (PD1-ACR) engineered lymphocytes for PDL1(+) cancer therapy 期刊论文 AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 卷号: 7, 期号: 3 作者:  Tang, Xiaolong;  Li, Qingguo;  Zhu, Yongqiang;  Zheng, Donghui;  Dai, Jingjing 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Programmed Death Ligand 1  phosphoinositide 3-kinase  cytotoxicity  activating chimeric receptor